UNSPSC 51295105: Clodazon hydrochloride

This classification denotes an antidepressant agent with the molecular formula C18H20ClN3O.ClH.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FSF9L5AH4G, chemically known as 2h-benzimidazol-2-one, 5-chloro-1(3-(dimethylamino)propyl)-1,3-dihydro-3-phenyl-, monohydrochloride, monohydrate but more generally known as clodazon hydrochloride, which bears US NIH Compound Identifier 167451. Most nations, for tariff and trade purposes, schedule clodazon hydrochloride under HS 29339990 and SITC 51577.

As of Q4 2014, CLODAZON HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Clodazon hydrochloride bears US NLM identifiers UMLS ID C2699360 and NCI Concept Code C78012. SMILES: CN(C)CCCN1C2CCC(CC2N(C1=O)C3CCCCC3)CL.O.CL.

UNSPSC 51295105 Clodazon hydrochloride is a Commodity code with minimal direct activity in recent state and local procurement. The three most recent opportunities tagged to this code involve naloxone procurement, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals — none of which target clodazon hydrochloride specifically. State and local health authorities and cooperative purchasing organizations are the primary issuing bodies, but the actual pharmaceutical products being solicited diverge substantially from the code's nominal scope. Seminole County, Florida (IFB 60459723LAS, response deadline July 26, 2023) sought naloxone and drug deactivation systems through competitive bidding with quarterly deliveries to support community health initiatives. The Texas Health and Human Services Commission issued a Request for Information on direct-to-manufacturer prescription fulfillment (HHS0017013, posted April 3, 2026) to explore vendor capacity for state pharmacy benefit programs, while the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) released an RFP for generic multi-source pharmaceuticals and OTC products (S1070000015802, response deadline March 26, 2026) to supply state and local government facilities across Minnesota and Oregon through authorized wholesalers.

Geographic activity clusters in Florida, Texas, and Minnesota based on the recent solicitations, though the code shows light overall recent activity and poor alignment between the nominal commodity and the work actually being bought. Issuing bodies include county health departments, state health and human services agencies, and cooperative purchasing consortia spanning multiple states. The MMCAP procurement represents the broadest scope, establishing multi-award contracts for generic pharmaceuticals effective July 1, 2026, with pricing evaluated on competitiveness (75 percent weight), compliance with regulatory and data-interchange requirements (15 percent), and fixed-price terms (10 percent). Vendors on all three opportunities must meet Good Manufacturing Practices, FDA compliance, insurance coverage thresholds, and E-Verify or equivalent workforce eligibility verification. The code's actual use in state and local procurement appears limited; if pursuing activity under this UNSPSC code, verify that your product or service aligns with the actual pharmaceutical categories being solicited rather than relying on the code name alone.